19410716

Source:http://linkedlifedata.com/resource/pubmed/id/19410716

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013216, umls-concept:C0030705, umls-concept:C0205179, umls-concept:C0282461, umls-concept:C0684249, umls-concept:C0995188
pubmed:issue	9674
pubmed:dateCreated	2009-5-4
pubmed:abstractText	Use of cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor (EGFR), has the potential to increase survival in patients with advanced non-small-cell lung cancer. We therefore compared chemotherapy plus cetuximab with chemotherapy alone in patients with advanced EGFR-positive non-small-cell lung cancer.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19410716-19410696
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985213R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor, http://linkedlifedata.com/resource/pubmed/chemical/Vinblastine, http://linkedlifedata.com/resource/pubmed/chemical/cetuximab, http://linkedlifedata.com/resource/pubmed/chemical/vinorelbine
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1474-547X
pubmed:author	pubmed-author:BajettaEmilioE, pubmed-author:EberhardtWilfriedW, pubmed-author:EmigMichaelM, pubmed-author:FLEX Study Team, pubmed-author:GanulValentynV, pubmed-author:GatzemeierUlrichU, pubmed-author:GoddemeierThomasT, pubmed-author:KrzakowskiMaciejM, pubmed-author:O'ByrneKennethK, pubmed-author:ParkKeunchilK, pubmed-author:PereiraJose RJR, pubmed-author:PirkerRobertR, pubmed-author:RamlauRodrygR, pubmed-author:RohJae-KyungJK, pubmed-author:SzczesnaAleksandraA, pubmed-author:VynnychenkoIhorI, pubmed-author:YuChih-TengCT, pubmed-author:de MarinisFilippoF, pubmed-author:von PawelJoachimJ
pubmed:issnType	Electronic
pubmed:day	2
pubmed:volume	373
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1525-31
pubmed:dateRevised	2009-11-19
pubmed:meshHeading	pubmed-meshheading:19410716-Adolescent, pubmed-meshheading:19410716-Adult, pubmed-meshheading:19410716-Aged, pubmed-meshheading:19410716-Aged, 80 and over, pubmed-meshheading:19410716-Antibodies, Monoclonal, pubmed-meshheading:19410716-Antineoplastic Agents, pubmed-meshheading:19410716-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19410716-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:19410716-Cisplatin, pubmed-meshheading:19410716-Female, pubmed-meshheading:19410716-Humans, pubmed-meshheading:19410716-Lung Neoplasms, pubmed-meshheading:19410716-Male, pubmed-meshheading:19410716-Middle Aged, pubmed-meshheading:19410716-Neoplasm Staging, pubmed-meshheading:19410716-Proportional Hazards Models, pubmed-meshheading:19410716-Receptor, Epidermal Growth Factor, pubmed-meshheading:19410716-Survival Analysis, pubmed-meshheading:19410716-Survival Rate, pubmed-meshheading:19410716-Treatment Outcome, pubmed-meshheading:19410716-Vinblastine, pubmed-meshheading:19410716-Young Adult
pubmed:year	2009
pubmed:articleTitle	Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial.
pubmed:affiliation	Medical University of Vienna, Vienna, Austria.
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III